Skip to main content
PharmaTher Holdings Ltd. logo

PharmaTher Holdings Ltd. — Investor Relations & Filings

Ticker · PHRM ISIN · CA71716H1082 LEI · 529900PIPSZ1ZSWF3A21 CSE Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2022-04-25 Annual Report
Country CA Canada
Listing CSE PHRM

About PharmaTher Holdings Ltd.

https://www.pharmather.com/

PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Annual Report Classification · 95% confidence The document is titled 'Notice annuelle' for the fiscal year ended December 31, 2021, and dated March 23, 2022. It contains detailed sections such as glossary, explanatory notes, business development, portfolio description, debt, governance, risk factors, market information, contracts, and auditor information. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content and structure align with a full annual report covering company activity and financial performance for the year. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2021
2022-04-25 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'PHARMATHER HOLDINGS LTD. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for the three and nine months ended February 28, 2022 and 2021. It contains detailed unaudited condensed interim consolidated financial statements including statements of financial position, loss and comprehensive loss, changes in equity, cash flows, and accompanying notes. The document explicitly states it is prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, and includes substantive financial data and analysis for a period shorter than a full fiscal year. The length of the document (15,000 characters) and the detailed financial content confirm it is a full interim report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-04-25 English
News release - English.pdf
Regulatory Filings
2022-04-12 English
News release - English.pdf
Regulatory Filings
2022-03-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the grant of a U.S. patent for a ketamine formulation by PharmaTher Holdings Ltd. It discusses the patent details, the company's intellectual property position, ongoing studies, and future plans. There is no financial data, regulatory filing, or report content such as annual or quarterly financial statements. It is not an earnings release, management report, or any form of financial or governance report. The document is a corporate announcement related to intellectual property and innovation, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2022-02-16 English
News release - English.pdf
Regulatory Filings
2022-02-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.